| Product Code: ETC6752944 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Sartans Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Sartans Market Revenues & Volume, 2021 & 2031F |
3.3 China Sartans Market - Industry Life Cycle |
3.4 China Sartans Market - Porter's Five Forces |
3.5 China Sartans Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 China Sartans Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 China Sartans Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 China Sartans Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of hypertension in China |
4.2.2 Growing awareness about the importance of cardiovascular health |
4.2.3 Rising adoption of generic sartans due to cost-effectiveness |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in China |
4.3.2 Competition from other classes of antihypertensive drugs |
4.3.3 Potential side effects associated with sartans impacting consumer confidence |
5 China Sartans Market Trends |
6 China Sartans Market, By Types |
6.1 China Sartans Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 China Sartans Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 China Sartans Market Revenues & Volume, By Valsartan, 2021- 2031F |
6.1.4 China Sartans Market Revenues & Volume, By Telmisartan, 2021- 2031F |
6.1.5 China Sartans Market Revenues & Volume, By Losartan, 2021- 2031F |
6.1.6 China Sartans Market Revenues & Volume, By Irbesartan, 2021- 2031F |
6.1.7 China Sartans Market Revenues & Volume, By Azilsartan, 2021- 2031F |
6.1.8 China Sartans Market Revenues & Volume, By Olmesartan, 2021- 2031F |
6.2 China Sartans Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 China Sartans Market Revenues & Volume, By Valsartan, 2021- 2031F |
6.2.3 China Sartans Market Revenues & Volume, By Telmisartan, 2021- 2031F |
6.2.4 China Sartans Market Revenues & Volume, By Losartan, 2021- 2031F |
6.2.5 China Sartans Market Revenues & Volume, By Irbesartan, 2021- 2031F |
6.2.6 China Sartans Market Revenues & Volume, By Azilsartan, 2021- 2031F |
6.2.7 China Sartans Market Revenues & Volume, By Olmesartan, 2021- 2031F |
6.3 China Sartans Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 China Sartans Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 China Sartans Market Revenues & Volume, By Diagnostic Laboratories, 2021- 2031F |
6.3.4 China Sartans Market Revenues & Volume, By Others, 2021- 2031F |
7 China Sartans Market Import-Export Trade Statistics |
7.1 China Sartans Market Export to Major Countries |
7.2 China Sartans Market Imports from Major Countries |
8 China Sartans Market Key Performance Indicators |
8.1 Prescription rate of sartans compared to other antihypertensive medications |
8.2 Patient adherence to sartan therapy |
8.3 Number of new sartan product launches with improved formulations |
8.4 Rate of hypertension diagnosis and treatment in China |
8.5 Number of clinical trials studying the efficacy and safety of sartans |
9 China Sartans Market - Opportunity Assessment |
9.1 China Sartans Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 China Sartans Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 China Sartans Market Opportunity Assessment, By End User, 2021 & 2031F |
10 China Sartans Market - Competitive Landscape |
10.1 China Sartans Market Revenue Share, By Companies, 2024 |
10.2 China Sartans Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here